User:Truwsetu3/sandbox

 Front Line COVID-19 Critical Care Alliance 

About/Overview

The Front Line COVID-19 Critical Care Alliance (FLCCC) formed in March 2020, during the earlier stages of the COVID-19 pandemic in the United States. An association of acclaimed experts on critical care, the FLCCC initially began for professionals to remain virtually connected in sharing updates and discussing the latest COVID-19 science.

As it stands one year later, the association’s priorities were redirected and focus on providing prevention and treatment protocols for COVID-19 to the world’s health care and related medical personnel- including researchers, scientists, physicians, professors, bio-pharmaceutical companies and hospitals/clinics. The Front Line Covid-19 Critical Care Alliance published two protocols for the treatment of COVID-19.

Their first protocol was the MATH+ Hospital Treatment Protocol, an early intervention standard that addressed the domestic supply and demand crisis for ventilator machines. Between March and July 2020, the nation was not prepared and equipped to support the surging demand for ventilator machines- and its parts- than what existing, attainable supply remained. The purpose for the development of MATH+ was to save the high-risk, critically ill patient population and avert them from relying on ventilators to breathe.

Following, the FLCCC developed the I-MASK+ Prevention & Early Outpatient Treatment Protocol, a standard brought together by the drug ivermectin, which also quietly includes vitamins C and D, quercetin, zinc, and melatonin. Advocating the efficacy of ivermectin in being effective for every phase of the COVID-19 strain, the FLCCC still urges the continuing cooperation of social distancing and mask mandates by the public.

What separates the Front Line COVID-19 Critical Care Alliance from other organizations and personnel is the methodology by which their suggested treatments and protocols are assessed. Relying heavily on mutual knowledge, experiences and research, the FLCCC disagrees how the clinical and scientific community practices evidence-based medicine. Unsupportive of the placebo’s given when conducting randomized controlled drug trials, the group’s experts value risk over reward: that the positive data will come with time after patients are given a dose of ivermectin. On the opposing end, research labs value patient safety over drug success, requiring several series of trials and a number approvals before any treatment is verified and approved for mass use.

The Early Treatment Approach

The FLCCC advocates early outpatient treatment, as resonated by other medical professionals such as Dr. Peter McCullough. Dr. McCullough gave his testimony in a senate hearing on 11/19/2020 stressing that early outpatient treatment is a crucial part of solving the Covid-19 crisis. He authored an article entitled "Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection" published in the American Journal of Medicine, August 2020.

The Association of American Physicians and Surgeons (AAPS) also published "A Guide to Home-Based COVID Treatment" stressing the key to success is early treatment. In this 26-page booklet, the AAPS encourages people to be their own advocate. It stated that "studies in the US and many other countries clearly show that patients who are treated within the first 5 days of symptoms have better outcomes using the combination of medications in the algorithm below. Conversely the death rate is ~12% by the time oxygen is needed, and ~40% for those requiring the intensive care unit. These death rates are unacceptably high. We have found that death rates can be significantly lower with early, outpatient treatment for the high-risk patients over age 50, with one or more other medical conditions".

The FLCCC also stresses on prevention measures that people should take to protect themselves from getting infected by the Covid1-19 virus. Their recommendations include:

Wearing Masks


 * Wear a cloth, surgical, or an N95 mask in indoor and outdoor spaces with non-household members
 * Must wear an N95 mask in poorly ventilated spaces with non-household members

Social Distancing


 * Keep a minimum distance of 6 feet from non-household members

Washing Hands


 * FLCCC recommends hand washing for 20-30 seconds (with soap) after returning from being away from your home
 * It is recommended to use a hand disinfectant if you are not able to wash your hands

Science Behind the FLCCC Covid-19 Treatment Recommendations

The FLCCC has expressed that wearing masks, keeping distance, washing hands, and many vitamins along with Ivermectin can all help to prevent or treat early COVID-19 cases. The science behind these practices is what is up for question.


 * Wearing masks is believed to be helping in many ways. The science behind masks is simple as it creates a barrier for any airborne liquids or germs. An important factor on the efficacy of masks is whether or not they have valves.


 * While the FLCCC recommends social distancing the science behind the 6 foot rule is not necessarily solid. A study found that smaller airborne droplets can spread up to 8 meters away, which is nearly 27 feet. It is unclear that this has had a significant spread factor but still is possible.
 * Washing hands is a major part in helping treat and prevent COVID-19. It is a fact that people touch their face all the time. Statistically it "reduces respiratory illnesses in the general population by 16-21%.
 * Vitamins have been shown to have great importance on treating COVID-19 and preventing it. The most important vitamin according to Walter Willett, professor of epidemiology and nutrition at Harvard T.H. Chan School of Public Health is Vitamin D. It is shown to have a promising impact on COVID-19 prevention and can even aid during infection.
 * According to the FLCCC Ivermectin has been very efficient with treating COVID-19. This drug is an anti-parasite drug which has shown to be extremely safe and effective through over 50 trials with almost 16,000 patients. With the use of this drug it is clear that there has been an improvement for many different treatment options for COVID-19. Though some doctors and advocates have endorsed Ivermectin, the clinical investigation of its effectiveness against COVID-19 is ongoing.

Perceptions from Government, Medical, Merck & Co Pharmaceutical Company and Some Covid-19 Patients

Although the FLCCC strongly advocates that ivermectin is effective in treating Covid-19 patients as well as in being used as a prophylactic agent quoting numerous studies, the FLCCC's approach has not yet been endorsed by government health agencies  and its manufacturer Merck Pharmaceutical Company. The World Health Organization issued a statement on March 31, 2021 advising that ivermectin can only be used in clinical trials to treat Covide-19 patients.

While widespread disagreement exist between government health agencies and the FLCCC on how to manage Covid-19 patients, a few court cases have been involved where Covid-19 patients' family members sought to seek court orders to force hospitals to use Ivermectin to treat their loved ones:
 * 1) The son of an 80-year-old woman, Judith Smentkiewicz, hired a lawyer to get an injunction to order Millard Fillmore Suburban Hospital to provide her ivermectin, she recovered after taking this off-label drug
 * 2) The daughter of a 65-year-old woman, Glenna “Sue” Dickinson, had to seek court intervention so that her mother could take Ivermectin, after she was not responding to the other treatment.
 * 3) The wife of an 85-year-old farmer, John W. Swanson, filed an affidavit to order a Batavia hospital to administer Ivermectin to her husband.